Posaconazole Intravenous and Ulipristal
Determining the interaction of Posaconazole Intravenous and Ulipristal and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Coadministration with CYP450 3A4 inhibitors may increase the plasma concentrations of ulipristal, which is primarily metabolized by the isoenzyme. The clinical relevance is unknown.
- "Product Information. ella (ulipristal)." Afaxys Inc., Charleston, SC.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Posaconazole Intravenous-Ulipristal Acetate
- Posaconazole Intravenous-Ulipristal Tablets (Ella)
- Posaconazole Intravenous-Uloric
- Posaconazole Intravenous-Ultacan
- Posaconazole Intravenous-Ultane
- Posaconazole Intravenous-Ultane Amerinet
- Ulipristal-Posaconazole Oral Suspension
- Ulipristal-Posaconazole oral/injection
- Ulipristal-Posaconazole Tablets
- Ulipristal-PosiFlush flush
- Ulipristal-Positive Skin Test Control - Histamine
- Ulipristal-Posture